Adiponectin activation of AMPK disrupts leptin-mediated hepatic fibrosis via suppressors of cytokine signaling (SOCS-3)
about
Endocrine causes of nonalcoholic fatty liver diseaseThe AMPK agonist AICAR inhibits TGF-β1 induced activation of kidney myofibroblastsAdiponectin agonist ADP355 attenuates CCl4-induced liver fibrosis in miceAdiponectin inhibits leptin signalling via multiple mechanisms to exert protective effects against hepatic fibrosisLeptin promotes fetal lung maturity and upregulates SP-A expression in pulmonary alveoli type-II epithelial cells involving TTF-1 activation.Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis.Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease.GLP-1 analogs reduce hepatocyte steatosis and improve survival by enhancing the unfolded protein response and promoting macroautophagy.Design and development of a peptide-based adiponectin receptor agonist for cancer treatment.Inhibition of leptin-induced vascular extracellular matrix remodelling by adiponectinLeptin promotes the myofibroblastic phenotype in hepatic stellate cells by activating the hedgehog pathway.Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease.Signal transducer and activator of transcription 3 in liver diseases: a novel therapeutic target.Adiponectin, a key adipokine in obesity related liver diseasesPotential role of leptin, adiponectin and three novel adipokines--visfatin, chemerin and vaspin--in chronic hepatitis.Association of genetic variants with rapid fibrosis: progression after liver transplantation for hepatitis C.Levels of adiponectin, a marker for PPAR-gamma activity, correlate with skin fibrosis in systemic sclerosis: potential utility as biomarker?Obesity Impairs Skeletal Muscle Regeneration Through Inhibition of AMPK.Adiponectin-derived active peptide ADP355 exerts anti-inflammatory and anti-fibrotic activities in thioacetamide-induced liver injuryAdiponectin as an anti-fibrotic and anti-inflammatory adipokine in the liver.Berberine Inhibition of Fibrogenesis in a Rat Model of Liver Fibrosis and in Hepatic Stellate Cells.Leptin increases mitotic index and regeneration ratio in hepatectomized rats.Plumbagin protects liver against fulminant hepatic failure and chronic liver fibrosis via inhibiting inflammation and collagen production.Exploiting the anti-inflammatory effects of AMP-activated protein kinase activation.Leptin and adiponectin: emerging therapeutic targets in breast cancer.Hepatitis C virus core protein stimulates fibrogenesis in hepatic stellate cells involving the obese receptor.New insight into inter-organ crosstalk contributing to the pathogenesis of non-alcoholic fatty liver disease (NAFLD).Ghrelin induces cell migration through GHS-R, CaMKII, AMPK, and NF-κB signaling pathway in glioma cells.Mammalian target of rapamycin mediates the angiogenic effects of leptin in human hepatic stellate cells.Adiponectin attenuates liver fibrosis by inducing nitric oxide production of hepatic stellate cells.AMPK: a novel target for treating hepatic fibrosisAcetate alters the process of lipid metabolism in rabbits.Energy-sensitive regulation of Na+/K+-ATPase by Janus kinase 2.Anti-neuroinflammatory effect of a novel caffeamide derivative, KS370G, in microglial cells.HMGCoA reductase inhibition reverses myocardial fibrosis and diastolic dysfunction through AMP-activated protein kinase activation in a mouse model of metabolic syndrome.Thiazolidinediones improve hepatic fibrosis in rats with non-alcoholic steatohepatitis by activating the adenosine monophosphate-activated protein kinase signalling pathway.Therapeutic Approaches to Nonalcoholic Fatty Liver Disease: Exercise Intervention and Related MechanismsAdiponectin as a novel biomarker for liver fibrosis
P2860
Q26780254-68C2CB0F-CA7B-44EC-8578-71E8469C80EEQ27312584-BDA46725-D01D-4EF1-9435-E41C532705D6Q28543721-DA24FB8B-4142-40CB-A283-F83D54CB451AQ28584013-4BAE01AA-3C9B-4708-9771-D5303F25F162Q33112091-A8EB427C-7FB6-40DF-A37F-DD6FF90EBCDCQ33687809-756C5613-8BD1-4ACB-9C39-97BE4C15239BQ33719929-0CA65C88-75D0-4B2E-A380-55DFEA4D044BQ34034795-0CC7D013-4341-47E1-B92B-AB82E73F8989Q34040946-4222DEDC-F778-4E7E-A1C3-1A79BCFBEA1AQ34118648-1B5F8906-053D-472D-ADA4-EB35A76D1794Q34299086-33ACD47F-CF32-43ED-995C-737F69DD77E1Q34779049-0F9A85BF-1E4C-489E-AADB-7DC6ED2B475CQ34940989-76F4F297-8826-4D62-A44B-4163BABAEC13Q35061908-C6A070A8-E664-424A-8176-776307EBF3F0Q35876759-1AB9D0EA-6A22-47F6-9F65-F89838F44335Q35915073-E1ACB2B3-4534-4FD9-B1B5-49B34E6A74BAQ36245922-CCC38B88-61F0-4DC5-BE0F-4DD181F4BCA4Q36392842-F6635A63-5F9C-4EC7-A348-188BC080C517Q36499724-25C8A54B-1C7B-4D7F-8799-9A2D971E34C0Q36551969-AB9958EF-1675-44BE-9E6F-3E41A9AD08F3Q36901429-B2B4733C-478E-4952-9547-24A3A27110E4Q37367177-182F5748-C6C1-42FA-B144-44F73C0220ECQ37696229-5803CB90-7BF7-45FD-AC87-EFA9633F7A60Q38018381-0C783999-FC2F-4486-BC71-2C23B4D4C78EQ38153628-F8127DFA-AA0C-4673-B205-09CE1A130286Q38321928-03BCD1DA-564D-40E8-BFE5-ED98333644D9Q39393326-1E0DF6AA-F9EF-48CE-B29C-417E546FDA09Q39532557-550EE88C-9314-4D3A-8D57-6DD43CF07DE7Q39605054-C6A65ADB-AFCF-42AC-9CAC-66B40C7F9A79Q40759563-29527744-E16D-4543-9324-5AAA37E32D9CQ42000401-13CE5216-C4C3-4070-A045-B175242712F9Q47337862-CC27BBE9-6BA1-4EB5-95CC-EDFFE92B621CQ48613326-46D655E7-D5AD-4367-A007-92EC6961CFECQ50878132-14D2C322-831E-4DEA-A75D-34FAC271BB6FQ54440549-4F920FF0-CBB7-4EB3-B054-DB5672A39553Q54468632-8303ECD1-69E0-43DF-AFCC-8C3F4E1B2733Q58122029-F18C65DF-5891-40EA-B75F-1848126428DFQ58603859-D956C1DC-6281-4767-BF7D-E277649E8F5C
P2860
Adiponectin activation of AMPK disrupts leptin-mediated hepatic fibrosis via suppressors of cytokine signaling (SOCS-3)
description
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2010
@ast
im August 2010 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2010/08/01)
@sk
vědecký článek publikovaný v roce 2010
@cs
wetenschappelijk artikel (gepubliceerd op 2010/08/01)
@nl
наукова стаття, опублікована в серпні 2010
@uk
مقالة علمية (نشرت في أغسطس 2010)
@ar
name
Adiponectin activation of AMPK ...... of cytokine signaling (SOCS-3)
@ast
Adiponectin activation of AMPK ...... of cytokine signaling (SOCS-3)
@en
Adiponectin activation of AMPK ...... of cytokine signaling (SOCS-3)
@nl
type
label
Adiponectin activation of AMPK ...... of cytokine signaling (SOCS-3)
@ast
Adiponectin activation of AMPK ...... of cytokine signaling (SOCS-3)
@en
Adiponectin activation of AMPK ...... of cytokine signaling (SOCS-3)
@nl
prefLabel
Adiponectin activation of AMPK ...... of cytokine signaling (SOCS-3)
@ast
Adiponectin activation of AMPK ...... of cytokine signaling (SOCS-3)
@en
Adiponectin activation of AMPK ...... of cytokine signaling (SOCS-3)
@nl
P2093
P2860
P3181
P356
P1476
Adiponectin activation of AMPK ...... of cytokine signaling (SOCS-3)
@en
P2093
Frank A. Anania
Jamie E. Mells
Jeffrey A. Handy
Neeraj K. Saxena
Nitika A. Gupta
Pingping Fu
Songbai Lin
P2860
P304
P3181
P356
10.1002/JCB.22634
P577
2010-08-01T00:00:00Z